PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 171 filers reported holding PRECIGEN INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $928,242 | +33.9% | 653,692 | +8.5% | 0.00% | 0.0% |
| Q2 2023 | $693,156 | -13.9% | 602,745 | -20.6% | 0.00% | 0.0% |
| Q1 2023 | $805,053 | -29.0% | 759,484 | +1.7% | 0.00% | 0.0% |
| Q4 2022 | $1,134,656 | -17.2% | 746,484 | +15.4% | 0.00% | -50.0% |
| Q3 2022 | $1,371,000 | +28.4% | 646,882 | -18.8% | 0.00% | +100.0% |
| Q2 2022 | $1,068,000 | -41.7% | 796,846 | -8.3% | 0.00% | -50.0% |
| Q1 2022 | $1,833,000 | +515.1% | 868,556 | +981.2% | 0.00% | – |
| Q4 2021 | $298,000 | -14.1% | 80,334 | +15.4% | 0.00% | – |
| Q3 2021 | $347,000 | -78.1% | 69,620 | -71.3% | 0.00% | -100.0% |
| Q2 2021 | $1,581,000 | -69.3% | 242,507 | -67.5% | 0.00% | -80.0% |
| Q1 2021 | $5,146,000 | -27.3% | 746,812 | +7.6% | 0.01% | -16.7% |
| Q4 2020 | $7,076,000 | +590.3% | 693,790 | +137.1% | 0.01% | +500.0% |
| Q3 2020 | $1,025,000 | -40.2% | 292,656 | -14.9% | 0.00% | -50.0% |
| Q2 2020 | $1,715,000 | +297.9% | 343,834 | +171.1% | 0.00% | +100.0% |
| Q1 2020 | $431,000 | – | 126,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |